SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s
Harvard Apparatus Regenerative Technology, Inc. has executed a Securities Purchase Agreement for the sale of unregistered securities, subject to the c...
The financial holding company announced a $0.19 quarterly cash dividend per common share, payable Oct. 1, declar......
Biofrontera announced FDA approval of Ameluz for superficial basal cell carcinoma, expanding the therapy's market reach. This approval establishes it ...
Cardiff Oncology, Inc. has executed an amendment to its license agreement with Nerviano Medical Sciences, effectively resolving ongoing legal disputes...
Ellington Financial Inc. plans to issue $100 million of 7.375% senior unsecured notes due 2030 through its subsidiaries. The company intends to use th...
Healthstream Inc. and its lenders entered into a Second Amendment to the Amended and Restated Revolving Credit Agreement dated October 6, 2023, effect...
Baldwin Insurance Group signed a definitive agreement to merge with Square Acquisition Parent in a deal valuing the company. The transaction is valued...
XBP Global Holdings announced a securities purchase agreement for financing, dated September 11, 2026. The company intends to sell securities to a gro...
Immersion Corp reported $294.4 million in Q1 Fiscal 2027 revenue and GAAP net income of $4.9 million, highlighting continued financial strength follow...
Phio Pharmaceuticals announced a formal submission to the U.S. FDA regarding nonclinical and clinical data for PH-762, intending to progress to a Phas...
Hyperliquid Strategies Inc amended a purchase agreement with Chardan Capital Markets to adjust the VWAP Purchase Price to 98.5% for standard trades an...
Future Vision II signed an unsecured promissory note with HWei Super Speed Co. Ltd., secured by a one-month extension to its business combination dead...
Bitmine reported total crypto, cash, and securities assets of $15.8 billion, including 4.9% of the Ethereum supply, representing major strategic holdi...
Summit's partner Akeso announced Phase III data showing ivonescimab significantly improved survival over pembrolizumab in PD-L1 positive patients, pro...
Bowman Consulting Group's go-shop period expired without receiving a superior proposal, leaving the previously announced all-cash $43.00 per share dea...
DeFi Dev Corp added 55,491 SOL to its treasury to reach 2.39 million, and announced an ATM offering for up to $300M of Series C Preferred Stock to fun...
Eos Energy Enterprises received an $87 million advance to fund its Line 2 at the Thorn Hill facility, bringing total DOE draws to $178 million, which ...
The company issued a forward-looking update on September 2026 regarding future financial results, loan performance, and sector risks. This release hig...
Dr. Albert Luderer, PhD, assumed the roles of Chairman and Interim Chief Executive Officer at Bionano Genomics effective September 14, 2026....
Graco Inc. announced it has appointed Richard B. Lewis, President and CEO of Donaldson Company, to its Board of Directors, effective December 3, 2026....